Charles M. Perou

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Charles M. Perou

Feb 4, 2025, 15:30 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the Breast Cancer Research Digest - a…

Dec 24, 2024, 07:42 | Science

Serena Di Cosimo: The prognostic value of residual tumor biology during neoadjuvant treatment in patients with HER2+ breast cancer

Serena Di Cosimo, Medical Director at IRCCS Foundation National Cancer Institute, Milan, shared a recent…

Dec 10, 2024, 18:36 | Drugs

Maryam Lustberg: Trametinib with or without Uprosertib in Metastatic TNBC

Maryam Lustberg, The Director of the Center for Breast Cancer at Smilow Cancer Hospital, shared…

Sep 29, 2024, 16:26 | Insight

Donald McDonnell: Exploring the interactions between estrogens and tumor immunity

Donald McDonnell, Professor at Department of Pharmacology and Cancer Biology at Duke University School of Medicine,…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023